2013
DOI: 10.1182/blood-2013-10-533174
|View full text |Cite
|
Sign up to set email alerts
|

Platelet von Willebrand factor: sweet resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 9 publications
0
3
0
1
Order By: Relevance
“…Another contributor to the differences in thrombus formation rates is the fact that thermal damage can activate platelets and the coagulation process (22). The results showing portal veins with higher expression of vWF, a key protein in platelet aggregation and subsequent thrombus growth, supports this biologic mechanism (23). The discrepancy in flow pattern between vessel types, coupled with the underlying differences in coagulation protein and gene expression serve as potential contributors to vessel thrombosis patterns seen in this in vivo study.…”
Section: Discussion (800)mentioning
confidence: 53%
“…Another contributor to the differences in thrombus formation rates is the fact that thermal damage can activate platelets and the coagulation process (22). The results showing portal veins with higher expression of vWF, a key protein in platelet aggregation and subsequent thrombus growth, supports this biologic mechanism (23). The discrepancy in flow pattern between vessel types, coupled with the underlying differences in coagulation protein and gene expression serve as potential contributors to vessel thrombosis patterns seen in this in vivo study.…”
Section: Discussion (800)mentioning
confidence: 53%
“…This may result in the formation of platelet-derived VWF strings that may even be more resistant to ADAMTS13 proteolysis. 10,32 Similar to endothelial cell-derived VWF strings, VWF strings from platelets could recruit new platelets and inflammatory cells resulting in platelet/leukocyte plugs that block the microvasculature and contribute to the no-reflow phenomenon. Interestingly, such platelet derived-VWF strings have been shown in vitro.…”
Section: Discussionmentioning
confidence: 99%
“…When the ADAMT13 is lacking in vivo, as in Thrombotic Thrombocytopenic Purpura (TTP) disease, the clearance time and amount of VWF are abnormal, leading to microvascular thrombosis and organ ischemic infraction [ 50 ]. Prospective population-based cohort studies have revealed that low plasma ADAMT13 levels are related to risk and poor outcomes in AIS [ 51 , 52 ]. These studies suggested that both decreased amount of ADAMT13 and abnormal microenvironment would affect ULVWF elimination.…”
Section: Discussionmentioning
confidence: 99%